altimmune glp-1 treatments are changing the game—not just for weight loss, but for overall metabolic health. Originally developed for type 2 diabetes, these medications are now helping people improve blood sugar control, reduce FDA Grants Breakthrough Therapy Designation
Description
Hims & Hers announced a $250 million share buyback program, but escalating GLP-1 price competition from Novo Nordisk overshadowed the news
Come to Renew Aesthetics for a treatment with Semaglutide near Bentonville, AR, and get the results you're looking for.
A KFYR+ exclusive
Metabolic Syndrome: Clinical Research &
Andrew Huberman explores how peptides, AI, and emerging technologies are reshaping American health
Patients across the country are now filing lawsuits against []
